First Human Trial Shows CBG Reduces Anxiety and Enhances Memory

Researchers find promising results for CBG, a lesser-known cannabinoid, in reducing anxiety and improving memory without intoxication.

The study involved 34 healthy cannabis users in a double-blind, placebo-controlled trial.
Participants reported significant reductions in anxiety and stress after taking 20 mg of hemp-derived CBG.
CBG unexpectedly improved participants' memory, allowing better recall of word lists.
The trial found minimal side effects and no cognitive or motor impairments from CBG.
Researchers stress the need for further studies to confirm findings and explore CBG's full potential.